Your browser doesn't support javascript.

Biblioteca Virtual em Saúde

Brasil

Home > Pesquisa > ()
Imprimir Exportar

Formato de exportação:

Exportar

Email
Adicionar mais destinatários
| |

Antibiotiques inhalés dans la prise en charge des bronchiectasies en dehors de la mucoviscidose. / [Inhaled antibiotics for the management of non cystic fibrosis bronchiectasis].

Berra, Gregory; Chappuis-Gisin, Émilie; Soccal, Paola M; Plojoux, Jérôme.
Rev Med Suisse; 13(583): 2001-2004, 2017 Nov 15.
Artigo em Francês | MEDLINE | ID: mdl-29143505
Bronchiectasis is irreversible bronchial dilatation associated with chronic respiratory symptoms. Management is aimed at reducing symptoms and slowing the progression of the disease by interrupting the vicious circle: bronchial infection, inflammation, altered mucociliary clearance, lung destruction. Unlike the literature on inhaled antibiotics in cystic fibrosis, literature data are limited and of low quality for bronchiectasis of other causes. However, new recommendations from the European Respiratory Society propose the conditional use of inhaled antibiotics to prevent repeated infectious exacerbations and to eradicate Pseudomonas aeruginosa colonization.
Selo DaSilva